These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22684887)

  • 1. Synthesis and biological evaluation of adenosines with heterobicyclic and polycyclic N(6)-substituents as adenosine A(1) receptor agonists.
    Gosling JI; Baker SP; Haynes JM; Kassiou M; Pouton CW; Warfe L; White PJ; Scammells PJ
    ChemMedChem; 2012 Jul; 7(7):1191-201. PubMed ID: 22684887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Irreversible Agonists Acting at the A
    Jörg M; Glukhova A; Abdul-Ridha A; Vecchio EA; Nguyen AT; Sexton PM; White PJ; May LT; Christopoulos A; Scammells PJ
    J Med Chem; 2016 Dec; 59(24):11182-11194. PubMed ID: 27958734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-Based Design, Synthesis, and In Vivo Antinociceptive Effects of Selective A
    Petrelli R; Scortichini M; Belardo C; Boccella S; Luongo L; Capone F; Kachler S; Vita P; Del Bello F; Maione S; Lavecchia A; Klotz KN; Cappellacci L
    J Med Chem; 2018 Jan; 61(1):305-318. PubMed ID: 29257884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5'-C-Ethyl-tetrazolyl-N(6)-substituted adenosine and 2-chloro-adenosine derivatives as highly potent dual acting A1 adenosine receptor agonists and A3 adenosine receptor antagonists.
    Petrelli R; Torquati I; Kachler S; Luongo L; Maione S; Franchetti P; Grifantini M; Novellino E; Lavecchia A; Klotz KN; Cappellacci L
    J Med Chem; 2015 Mar; 58(5):2560-6. PubMed ID: 25699637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of novel allosteric enhancers of the A1 adenosine receptor based on 2-amino-3-(4'-chlorobenzoyl)-4-substituted-5-arylethynyl thiophene.
    Romagnoli R; Baraldi PG; IJzerman AP; Massink A; Cruz-Lopez O; Lopez-Cara LC; Saponaro G; Preti D; Aghazadeh Tabrizi M; Baraldi S; Moorman AR; Vincenzi F; Borea PA; Varani K
    J Med Chem; 2014 Sep; 57(18):7673-86. PubMed ID: 25181013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of adenosines with heterocyclic N6-substituents.
    Ashton TD; Aumann KM; Baker SP; Schiesser CH; Scammells PJ
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6779-84. PubMed ID: 17967536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N6-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine A1 receptor.
    Beukers MW; Wanner MJ; Von Frijtag Drabbe Künzel JK; Klaasse EC; IJzerman AP; Koomen GJ
    J Med Chem; 2003 Apr; 46(8):1492-503. PubMed ID: 12672250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-amino-6-alkyloxy-2-alkylthiopyrimidine derivatives as novel non-nucleoside agonists for the adenosine A
    Cosimelli B; Greco G; Laneri S; Novellino E; Sacchi A; Trincavelli ML; Giacomelli C; Taliani S; Da Settimo F; Martini C
    Chem Biol Drug Des; 2016 Nov; 88(5):724-729. PubMed ID: 27282729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and in Vivo Characterization of A
    Tosh DK; Rao H; Bitant A; Salmaso V; Mannes P; Lieberman DI; Vaughan KL; Mattison JA; Rothwell AC; Auchampach JA; Ciancetta A; Liu N; Cui Z; Gao ZG; Reitman ML; Gavrilova O; Jacobson KA
    J Med Chem; 2019 Feb; 62(3):1502-1522. PubMed ID: 30605331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and characterization of novel 2-amino-3-benzoylthiophene derivatives as biased allosteric agonists and modulators of the adenosine A(1) receptor.
    Valant C; Aurelio L; Devine SM; Ashton TD; White JM; Sexton PM; Christopoulos A; Scammells PJ
    J Med Chem; 2012 Mar; 55(5):2367-75. PubMed ID: 22315963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of a new series of 2-amino-3-aroyl thiophene derivatives as agonist allosteric modulators of the A1 adenosine receptor. A position-dependent effect study.
    Romagnoli R; Baraldi PG; Lopez-Cara C; Cruz-Lopez O; Moorman AR; Massink A; IJzerman AP; Vincenzi F; Borea PA; Varani K
    Eur J Med Chem; 2015 Aug; 101():185-204. PubMed ID: 26141910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor.
    Bosch MP; Campos F; Niubó I; Rosell G; Díaz JL; Brea J; Loza MI; Guerrero A
    J Med Chem; 2004 Jul; 47(16):4041-53. PubMed ID: 15267242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-kinetics relationships of Capadenoson derivatives as adenosine A1 receptor agonists.
    Louvel J; Guo D; Soethoudt M; Mocking TA; Lenselink EB; Mulder-Krieger T; Heitman LH; IJzerman AP
    Eur J Med Chem; 2015 Aug; 101():681-91. PubMed ID: 26210506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New 2,N6-disubstituted adenosines: potent and selective A1 adenosine receptor agonists.
    Hutchinson SA; Baker SP; Scammells PJ
    Bioorg Med Chem; 2002 Apr; 10(4):1115-22. PubMed ID: 11836122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of novel N6-[4-(substituted)sulfonamidophenylcarbamoyl]adenosine-5'-uronamides as A3 adenosine receptor agonists.
    Baraldi PG; Fruttarolo F; Tabrizi MA; Romagnoli R; Preti D; Bovero A; Pineda de Las Infantas MJ; Moorman A; Varani K; Borea PA
    J Med Chem; 2004 Oct; 47(22):5535-40. PubMed ID: 15481989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and structure-activity relationships of 1-,3-,8-, and 9-substituted-9-deazaxanthines at the human A2B adenosine receptor.
    Carotti A; Cadavid MI; Centeno NB; Esteve C; Loza MI; Martinez A; Nieto R; Raviña E; Sanz F; Segarra V; Sotelo E; Stefanachi A; Vidal B
    J Med Chem; 2006 Jan; 49(1):282-99. PubMed ID: 16392813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N6-substituted C5'-modified adenosines as A1 adenosine receptor agonists.
    Ashton TD; Baker SP; Hutchinson SA; Scammells PJ
    Bioorg Med Chem; 2008 Feb; 16(4):1861-73. PubMed ID: 18042389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of adenosine A(1) receptor biased agonism: Implications for drug discovery.
    Baltos JA; Gregory KJ; White PJ; Sexton PM; Christopoulos A; May LT
    Biochem Pharmacol; 2016 Jan; 99():101-12. PubMed ID: 26581123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N6-Cycloalkyl- and N6-bicycloalkyl-C5'(C2')-modified adenosine derivatives as high-affinity and selective agonists at the human A1 adenosine receptor with antinociceptive effects in mice.
    Franchetti P; Cappellacci L; Vita P; Petrelli R; Lavecchia A; Kachler S; Klotz KN; Marabese I; Luongo L; Maione S; Grifantini M
    J Med Chem; 2009 Apr; 52(8):2393-406. PubMed ID: 19317449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.